Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

Spotlight

04.29.14 Allena Pharmaceuticals Announces Positive Phase 1 Data of ALLN-177 for the Treatment of Kidney Stones

01.15.14 Allena Pharmaceuticals to Present at the 2014 J.P. Morgan Healthcare Conference